S.Biomedics Co., Ltd. (KOSDAQ:304360)

South Korea · Delayed Price · Currency is KRW

36,850

+2,250 (6.50%)

At close: Apr 29, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	16.55B	13.73B	13.11B	12.11B	8.87B
Pharmaceuticals Growth	20.49%	4.77%	8.22%	36.58%	66.72%
Total	16.55B	13.73B	13.11B	12.11B	8.87B
Total Growth	20.49%	4.77%	8.22%	36.58%	66.72%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	15.88B	2.35B	1.89B	1.73B	920.03M
South Korea Growth	575.24%	24.30%	9.59%	87.68%	-54.76%
Overseas	664.70M	11.38B	11.22B	10.39B	7.95B
Overseas Growth	-94.16%	1.48%	7.99%	30.67%	141.91%
Total	16.55B	13.73B	13.11B	12.11B	8.87B
Total Growth	20.49%	4.77%	8.22%	36.58%	66.72%

Source: S&P Global Market Intelligence.